Bharat Biotech's Covid-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said
from Latest News https://ift.tt/2QbCaFN
Tuesday, 11 May 2021
Experts recommend Covaxin for phase 2/3 trials on those aged 2-18 year
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment